We found that canagliflozin mediated activation of AMPK, inhibition of ACC and the mTOR‐HIF‐1α pathway, and an associated suppression of the mitosis marker, p‐H3Ser10, in NSCLC cells. Here, HIF1A is linked to non-small cell lung carcinoma.